Iron homeostasis in osteoporosis and its clinical implications

Osteoporosis International

Volumn 23, Issue 10, 2012, Pages 2403-2408

  Li, G F ^a   Pan, Y Z ^a   Sirois, P ^b   Li, K ^a   Xu, Y J ^a  

^a SOOCHOW UNIVERSITY   (China)

^b IPS Therapeutique Inc   (Canada)

Author keywords

Hepcidin; Iron overload; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM CHANNEL BLOCKING AGENT; CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE; EDETIC ACID; FERROPORTIN; HEPCIDIN; HYDROXYAPATITE; IRON; NIMODIPINE;

AGED; AGING; BLOOD TRANSFUSION; BONE CELL; BONE DENSITY; BONE METABOLISM; CELL DIFFERENTIATION; CELL METABOLISM; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG TARGETING; ESTROGEN DEFICIENCY; FEMALE; FEMUR NECK; FEMUR NECK FRACTURE; FRACTURE; HEMOCHROMATOSIS; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; IRON OVERLOAD; LUMBAR SPINE; MENOPAUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; OXIDATIVE STRESS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TEA; THALASSEMIA;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; OSTEOPOROSIS;

EID: 84867334961     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-1982-1     Document Type: Review

References (85)

1. Delbarre F (1960) Osteoporosis in hemochromatosis. Sem Hop 36:3279-3294
2. Delbarre F (1964) Osteoarticular manifestations of hemochromatosis. Presse Med 72:2973-2978
3. Duquenne M, Rohmer V, Legrand E, Chappard D, Wion Barbot N, Basle MF, Audran M, Bigorgne JC (1996) Spontaneous multiple vertebral fractures revealed primary haemochromatosis. Osteoporos Int 6(4):338-340
4. Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA (1992) Osteoporotic fractures: an unusual presentation of haemochromatosis. Bone 13(6):431-433
5. Kagan IE, Settarova DA, Tokarev Iu. N, Burdina LM (1989) Roentgenologic studies of changes of the osteoarticular system in patients with hereditary hemochromatosis. Gematol Transfuziol 34(10):19-24
6. Sella EJ, Goodman AH (1973) Arthropathy secondary to transfusion hemochromatosis. J Bone Joint Surg Am 55(5):1077-1081
7. Wardle EN, Patton JT (1969) Bone and joint changes in haemochromatosis. Ann Rheum Dis 28(1):15-23
8. Nicolino J, Lucciani JM (1967) Apropos of osteoarthropathies in idiopathic hemochromatoses. Diabete 15(3):196-200
9. Du Lac Y, Deloux G, Deuil R (1967) Arthropathies and chondrocalcinosis during hemochromatosis. Rev Rhum Mal Osteoartic 34(12):758-769
10. Dorfmann H, Solnica J, Mitrovic D, Dreyfus P (1969) Changes of bones and joints in hemochromatosis. Munch Med Wochenschr 111(25):1396-1401
11. Lynch SR, Seftel HC, Wapnick AA, Charlton RW, Bothwell TH (1970) Some aspects of calcium metabolism in normal and osteoporotic Bantu subjects with special reference to the effects of iron overload and ascorbic acid depletion. S Afr J Med Sci 35(2):45-56
12. de Seze S, Solnica J, Mitrovic D, Miravet L, Dorfmann H (1972) Joint and bone disorders and hypoparathyroidism in hemochromatosis. Semin Arthritis Rheum 2(1):71-94
13. Sabando P, Miravet L, Dorfman H, Kahn MF, Tun Chot S, Bordier P, Hioco D, De Seze S (1973) The osteopathy of hemochromatosis. Clinical and biological study. Rev Clin Esp 129(6):545-550
14. Urbina B, de Miguel Mendieta E, Gijon-Banos JG (1983) Joint disease in idiopathic hemochromatosis. Rev Rhum Mal Osteoartic 50(8-9):585-587
15. Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110(6):430-436
16. Conte D, Caraceni MP, Duriez J, Mandelli C, Corghi E, Cesana M, Ortolani S, Bianchi PA (1989) Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 84(10):1231-1234
17. Axford JS (1991) Rheumatic manifestations of haemochromatosis. Baillieres Clin Rheumatol 5(2):351-365
18. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24(9):1809-1813
19. Zeevaert B, Crielaard JM (1999) Osteoarticular hemochromatosis. Rev Med Liege 54(3):169-174
20. Vaiopoulos G, Papanikolaou G, Politou M, Jibreel I, Sakellaropoulos N, Loukopoulos D (2003) Arthropathy in juvenile hemochromatosis. Arthritis Rheum 48(1):227-230
21. Rollot F, Wechsler B, du Boutin le TH, De Gennes C, Amoura Z, Hachulla E, Piette JC (2005) Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? J Rheumatol 32(2):376-378
22. Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16(12):1809-1814
23. Chales G, Guggenbuhl P, Pawlotsky Y (2006) Iron overload and arthropathy. Rev Prat 56(19):2135-2140
24. Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L (2009) Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20(4):549-555
25. Richette P, Ottaviani S, Vicaut E, Bardin T (2010) Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 37(10):2145-2150
26. Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chales G, Loreal O, Chappard D (2011) Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int 22(8):2313-2319
27. Guggenbuhl P, Brissot P, Loreal O (2011) Haemochromatosis: the bone and the joint. Best Pract Res Clin Rheumatol 25(5):649-664
28. Lorincz G, Traub NE, Chuke PO, Hussain SF (1974) African haemosiderosis associated with osteoporosis and vertebral collapse. East Afr Med J 51(6):488-495
29. Schnitzler CM, Macphail AP, Shires R, Schnaid E, Mesquita JM, Robson HJ (1994) Osteoporosis in African hemosiderosis: role of alcohol and iron. J Bone Miner Res 9(12):1865-1873
30. Schnitzler CM, Schnaid E, MacPhail AP, Mesquita JM, Robson HJ (2005) Ascorbic acid deficiency, iron overload and alcohol abuse underlie the severe osteoporosis in black African patients with hip fractures-a bone histomorphometric study. Calcif Tissue Int 76(2):79-89
31. Rioja L, Girot R, Garabedian M, Cournot-Witmer G (1990) Bone disease in children with homozygous beta-thalassemia. Bone Miner 8(1):69-86
32. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R (2003) Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 88(8):3966-3972
33. Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 127(2):127-139
34. Salama OS, Al-Tonbary YA, Shahin RA, Eldeen OA (2006) Unbalanced bone turnover in children with beta-thalassemia. Hematology 11(3):197-202
35. Haidar R, Mhaidli H, Musallam K, Taher AT (2012) The spine in beta thalassemia syndromes. Spine (Phila Pa 1976) 37(4):334-339
36. Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136(4):666-672
37. Sadat-Ali M, Sultan O, Al-Turki H, Alelq A (2011) Does high serum iron level induce low bone mass in sickle cell anemia? Biometals 24(1):19-22
38. Wibaux C, Legroux-Gerot I, Dharancy S, Boleslawski E, Declerck N, Canva V, Mathurin P, Pruvot FR, Cortet B (2011) Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine 78(4):387-391
39. Topcheeva ON (2010) Hepatic osteodystrophy in patients with liver cirrhosis. Eksp Klin Gastroenterol 6:89-94
40. Loria I, Albanese C, Giusto M, Galtieri PA, Giannelli V, Lucidi C, Di Menna S, Pirazzi C, Corradini SG, Mennini G, Rossi M, Berloco P, Merli M (2010) Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc 42(4):1191-1193
41. Goral V, Simsek M, Mete N (2010) Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol 16(13):1639-1643
42. Smith DL, Shire NJ, Watts NB, Schmitter T, Szabo G, Zucker SD (2006) Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J Clin Densitom 9(1):105-113
43. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S (1990) Osteoporosis and skeletal fractures in chronic liver disease. Gut 31(1):82-87
44. Long RG, Meinhard E, Skinner RK, Varghese Z, Wills MR, Sherlock S (1978) Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut 19(2):85-90
45. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276(11):7806-7810
46. Youjia Xu, Pierre Sirois, Kai Li (2010) Iron overload plays a unique role in osteoporosis. [E-letter] Blood (9 Sep. 2010). http://bloodjournal. hematologylibrary.org/content/116/14/2582.full/replyloodjournal-el-524. Accessed 9 Sep. 2010
47. Xi Huang (2010) Treatment of osteoporosis in peri-and postmenopausal women with hepcidin. United States Patent Application Publication, Pub. No.: US 2010/0204122 A1
48. Xu Y, Li G, Du B, Zhang P, Xiao L, Sirois P, Li K (2011) Hepcidin increases intracellular Ca2+ of osteoblast hFOB1.19 through Ltype Ca2+ channels. Regul Pept 172(1-3):58-61
49. Xu Y, Zhang W, Zhang P, Xiao L, Wang A, Sirois P, Li K (2012) Downregulation of ferroportin 1 expression in hFOB1.19 osteoblasts by hepcidin. Inflammation. doi:10.1007/s10753-011-9411-8
50. Merono T, Sorroche P, Brites FD (2011) Increased iron store and its relationship with cardiovascular disease. Medicina (B Aires) 71(6):566-572
51. Sipe JC, Lee P, Beutler E (2002) Brain iron metabolism and neurodegenerative disorders. Dev Neurosci 24(2-3):188-196
52. Aamodt AH, Stovner LJ, Thorstensen K, Lydersen S, White LR, Aasly JO (2007) Prevalence of haemochromatosis gene mutations in Parkinson's disease. J Neurol Neurosurg Psychiatry 78(3):315-317
53. Gille G, Reichmann H (2011) Iron-dependent functions of mitochondria-relation to neurodegeneration. J Neural Transm 118(3):349-359
54. Guggenbuhl P, Filmon R, Mabilleau G, Basle MF, Chappard D (2008) Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism 57(7):903-910
55. Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191(2-3):211-215
56. Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25(1):164-172
57. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85
58. Fridovich I (1978) The biology of oxygen radicals. Science 201(4359):875-880
59. Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolagas SC (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor-to forkhead box O-mediated transcription. J Biol Chem 282(37):27298-27305
60. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382(6592):638-642
61. Qu ZH, Zhang XL, Tang TT, Dai KR (2008) Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 370(2):332-337
62. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15(3):259-266
63. Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116(14):2582-2589
64. Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197(2):93-100
65. Kudo H, Suzuki S, Watanabe A, Kikuchi H, Sassa S, Sakamoto S (2008) Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats. Toxicology 246(2-3):143-147
66. Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crifo A, Meo A, Frisina N (2007) The "lively" cytokines network in betathalassemia major-related osteoporosis. Bone 40(6):1588-1594
67. Jian J, Pelle E, Huang X (2009) Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11(12):2939-2943
68. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K (2000) LEAP-1, a novel highly disulfidebonded human peptide, exhibits antimicrobial activity. FEBS Lett 480(2-3):147-150
69. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276(11):7811-7819
70. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2(USF2) knockout mice. Proc Natl Acad Sci USA 98 (15):8780-8785
71. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99(7):4596-4601
72. Fleming RE, Sly WS (2001) Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98(15):8160-8162
73. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090-2093
74. Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323-342
75. Ganz T, Nemeth E (2006) Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 290(2):G199-G203
76. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, Kaplan J (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18(7):2569-2578
77. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T (2005) Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106(6):2196-2199
78. Ma Y, Youjia Xu, Wang A et al (2006) A preliminary report of expression of hepcidin gene in SD rats osteoporosis model. Suzhou Univ J Med Sci 26:367-369
79. Zhang P, Xu YJ, Zhao DY, Ma Y, Xiao L, Feng YS, Du BC, Qian ZM, Li K (2010) Increased intracellular iron and mineralization of cultured hFOB 1.19 cells following hepcidin activation through ferroportin-1. Saudi Med J 31(12):1303-1308
80. Ma Y, Xu Y (2010) Research on relationship between FPN1 content and effect of hepcidin on intracellular calcium and iron change in osteoblasts. Bone 47(1):406
81. Liu G, Men P, Kenner GH, Miller SC (2006) Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation. Biometals 19(3):245-251
82. Weinberg ED (2006) Iron loading: a risk factor for osteoporosis. Biometals 19(6):633-635
83. Wu CH, Yang YC, Yao WJ, Lu FH, Wu JS, Chang CJ (2002) Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med 162(9):1001-1006
84. Liu G, Men P, Kenner GH, Miller SC (2008) Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin 32(1-2):181-190
85. Cornish J, Palmano K, Callon KE, Watson M, Lin JM, Valenti P, Naot D, Grey AB, Reid IR (2006) Lactoferrin and bone; structure-activity relationships. Biochem Cell Biol 84(3):297-302